this post was submitted on 21 Jun 2026
491 points (99.0% liked)

Uplifting News

19186 readers
908 users here now

Welcome to /c/UpliftingNews (rules), a dedicated space where optimism and positivity converge to bring you the most heartening and inspiring stories from around the world. We strive to curate and share content that lights up your day, invigorates your spirit, and inspires you to spread positivity in your own way. This is a sanctuary for those seeking a break from the incessant negativity and rage (e.g. schadenfreude) often found in today's news cycle. From acts of everyday kindness to large-scale philanthropic efforts, from individual achievements to community triumphs, we bring you news—in text form or otherwise—that gives hope, fosters empathy, and strengthens the belief in humanity's capacity for good, from a quality outlet that does not publish bad copies of copies of copies.

Here in /c/UpliftingNews, we uphold the values of respect, empathy, and inclusivity, fostering a supportive and vibrant community. We encourage you to share your positive news, comment, engage in uplifting conversations, and find solace in the goodness that exists around us. We are more than a news-sharing platform; we are a community built on the power of positivity and the collective desire for a more hopeful world. Remember, your small acts of kindness can be someone else's big ray of hope. Be part of the positivity revolution; share, uplift, inspire!

founded 3 years ago
MODERATORS
 

"This is the first study to show that [the compound] Cu(ATSM) can increase the abundance of P-gp clearance pumps in an Alzheimer's model, by 24.1 percent, effectively linking the repair of the blood-brain barrier to a reduction in toxic proteins and improved cognitive function," Dr. Pyun said.

"By improving the pumps, the brain can finally clear out the trapped waste. Over 56 days, the treatment reduced toxic amyloid-beta by 42 percent and improved spatial learning by nearly 44 percent."

"Cu(ATSM) is a copper compound with anti-inflammatory and neuroprotective properties that has already progressed to clinical testing for conditions like Parkinson's and ALS," Professor Nicolazzo said.

you are viewing a single comment's thread
view the rest of the comments
[–] JasonDJ@lemmy.zip 9 points 18 hours ago

Wdym? If a drug like this were successful, everybody with any markers for Alzheimer's would want to be in on it. They'd make bank for several years, until the patent expires, and then they'd have other methods of extending the patent and prolonging market exclusivity.

Sorry but this is a shit talking point. What drug companies fear is the eradication of an ailment, and particularly by non-pharmaceutical means (i.e. gene therapy).

Even something that's 100% effective in preventing Alzheimer's, would still see a hell of a market.

And if such a drug is possible, then there's the game theory question. Any pharma exec knows that if their company can make a breakthrough medicine...so too could another company. Is it worth it for them to sit on it, only for another company to make the same discovery a year or two later and bring it to market?